1. Abe H, Honma S, Shiohara K, Honma K. Substance P receptor regulates the photic induction of Fos-like protein in the suprachiasmatic nucleus of Syrian hamsters. Brain Res 1996;708:135-142.

2. Abe H, Rusak B, Robertson HA. NMDA and non-NMDA antagonists inhibit photic induction of Fos protein in the hamster suprachiasmatic nucleus. Brain Res Bull 1992;28:831-835.

3. Amir S, Robinson B, Edelstein K. Distribution of NADPH-diaphorase staining and light-induced Fos expression in the rat suprachiasmatic nucleus region supports a role for nitric oxide in the circadian system. Neuroscience 1995;69:545-555.

4. Biello SM, Janik D, Mrosovsky N. Neuropeptide Y and behaviorally induced phase shifts. Neuroscience 1994;62:273-279.

5. Bina KG, Rusak B, Semba K. Localization of cholinergic neurons in the forebrain and brainstem that project to the suprachiasmatic nucleus of the hypothalamus in rats. J Comp Neurol 1993;335:295-307.

6. Bos NPA, Mirmiran M. Effects of excitatory and inhibitory amino acids on neuronal discharges in the cultured suprachiasmatic nucleus. Brain Res Bull 1993;31:67-72.

7. Cassone VM. Melatonin and suprachiasmatic nucleus function. In: Klein DC, Moore RY, Reppert SM, eds. The suprachiasmatic nucleus: The mind's clock. New York: Oxford Univ. Press, 1991;77-106.

8. Castel M, Belenky M, Cohen S, Ottersen OP, Storm-Mathisen J. Glutamate-like immunoreactivity in retinal terminals of the mouse suprachiasmatic nucleus. Eur J Neurosci 1993;5:368-372.

9. Chen G, van den Pol AN. Multiple NPY receptors coexist in pre-and postsynaptic sites: Inhibition of GABA release in isolated self-innervating SCN neurons. J Neurosci 1996;16:7711-7724.

10. Cohen RA, Albers HE. Disruption of human circadian and cognitive regulation following a discrete hypothalamic lesion: A case study. Neurology 1991;41:726-729.

11. Colquhoun P. Rhythms in performance. In: Aschoff J, ed. Handbook of behavioral neurobiology: Biological rhythms. New York: Plenum Press, 1981;333-348.

12. Colwell CS, Kaufman CM, Menaker M. Phase shifting mechanisms in the mammalian circadian system: new light on the carbachol paradox. J Neurosci 1993;13:1454-1459.

13. Colwell CS, Menaker M. NMDA as well as non-NMDA receptor antagonists can prevent the phase shifting effects of light on the circadian system of the golden hamster. J Biol Rhythms 1992;7:125-136.

14. Colwell CS, Menaker M. Regulation of circadian rhythms by excitatory amino acids. In: Brann DW, Mahesh VB, eds. Excitatory amino acids: Their role in neuroendocrine function. New York: CRC Press, 1996;223-252.

15. Cote NK, Harrington ME. Histamine phase shifts the circadian clock in a manner similar to light. Brain Res 1993;613:149-151.

16. Czeiler CA. The effect of light on the human circadian pacemaker. In: Chadwick DJ, Ackrill K, eds. Circadian clocks and their adjustment. New York: John Wiley, 1995;254-289.

17. Deacon S, Arendt J. Adapting to phase shifts: Effects of melatonin and conflicting light treatment. Physiol Behav 1996;59:675-682.

18. Decavel C, van den Pol AN. GABA: A dominant transmitter in the hypothalamus. J Comp Neurol 1990;302:1019-1037.

19. DeVries MJ, Cardozo BN, van der Want J, de Wolf A, Meijer JH. Glutamate immunoreactivity in terminals of the retinohypothalamic tract of the brown Norwegian rat. Brain Res 1993;612:231-235.

20. Ding JM, Chen D, Weber ET, Faiman LE, Rea MA, Gillette MU. Resetting the SCN biological clock: mediation of nocturnal circadian phase shifts by glutamate and NO. Science 1994;266:1713-1717.

21. Dollins AB, Zhdanova IV, Wurtman RJ, Lynch HJ, Deng MH. Effect of inducing nocturnal serum melatonin concentrations in daytime on sleep, mood, body temperature, and performance. Proc Natl Acad Sci USA 1994;91:1824-1828.

22. Earnest DJ, Digiorgio SM, Sladek CD. Effects of tetrodotoxin on the circadian pacemaker mechanism in suprachiasmatic explants in vitro. Brain Res Bull 1991;26:677-682.

23. Earnest DJ, Sladek CD. Mechanisms underlying the acute and circadian release of vasopressin from explants containing the SCN. Brain Res 1986;382:129-133.

24. Earnest DJ, Sladek CD, Gash DM, Wiegand SJ. Specificity of circadian function in transplants of the fetal suprachiasmatic nucleus. J Neurosci 1989;9:2671-2677.

25. Ebling FJP, Maywood ES, Staley K, et al. The role of NMDA-type glutaminergic neurotransmission in the photic induction of immediate-early gene expression in the suprachiasmatic nuclei of the Syrian hamster. J Neuroendocrinol 1991;3:641-652.

26. Edgar DM, Miller JD, Prosser RA, Dean RR, Dement WC. Serotonin and the mammalian circadian system: phase shifting rat behavioral rhythms with serotonergic agonists. J Biol Rhythms 1993;8:17-31.

27. Focan C. Circadian rhythms and cancer chemotherapy. Pharmacol Ther 1995;67:1-52.

28. Gannon RL, Rea MA. In situ hybridization of antisense mRNA oligonucleotides for AMPA, NMDA and metabotropic glutamate receptor subtypes in the rat suprachiasmatic nucleus at different phases of the circadian cycle. Mol Brain Res 1994;23:338-344.

29. Garfinkel D, Laudon M, Nof D, Zisapel N. Improvement of sleep quality in elderly people by controlled-release melatonin. Lancet 1995;346:541-544.

30. Gillette MU. SCN electrophysiology in vitro: Rhythmic activity and endogenous clock properties. In: Klein DC, Moore RY, Reppert SM, eds. The suprachiasmatic nucleus: The mind's clock. New York: Oxford Univ. Press, 1991;125-143.

31. Halberg F, Johnson E, Brown W, Bittner JJ. Susceptibility rhythm to E. coli endotoxin and bioassay. Proc Soc Exp Biol Med 1960;103:142-144.

32. Hall JC. Tripping along the trail to the molecular mechanisms of biological clocks. Trends Neurosci 1995;18:230-240.

33. Harrington ME, Rusak B. Photic responses of geniculo-hypothalamic tract neurons in the Syrian hamster. Vis Neurosci 1989;2:367-375.

34. Healy D, Waterhouse JM. The circadian system and the therapeutics of the affective disorders. Pharmacol Ther 1995;65:241-263.

35. Honrado GI, Johnson RS, Golombek DA, Spiegelman BM, Papaioannou VE, Ralph MR. The circadian system of c-fos deficient mice. J Comp Physiol 1996;178:563-570.

36. Huhman KL, Babagbemi TO, Albers HE. Bicuculline blocks neuropeptide Y-induced phase advances when microinjected in the suprachiasmatic nucleus of Syrian hamsters. Brain Res 1995;675:333-336.

37. Inouye ST, Kawamura H. Persistence of circadian rhythmicity in a mammalian hypothalamic "island" containing the suprachiasmatic nucleus. Proc Natl Acad Sci USA 1979;76:5962-5966.

38. Inouye ST, Shibata S. Neurochemical organization of circadian rhythm in the suprachiasmatic nucleus. Neurosci Res 1994;20:109-130.

39. Jiang ZG, Allen CN, North RA. Presynaptic inhibition by baclofen of retinohypothalamic excitatory synaptic transmission in rat suprachiasmatic nucleus. Neuroscience 1995;64:813-819.

40. Jiang ZG, Nelson CS, Allen CN. Melatonin activates an outward current and inhibits IH in rat suprachiasmatic nucleus neurons. Brain Res 1995;687:125-132.

41. Johnson RF, Smale L, Moore RY, Morin LP. Lateral geniculate lesions block circadian phase-shift responses to a benzodiazepine. Proc Nat Acad Sci USA 1988;85:5301-5304.

42. Kim YI, Dudek FE. Intracellular electrophysiological study of suprachiasmatic nucleus neurons in rodents: excitatory synaptic mechanisms. J Physiol 1991;444:269-287.

43. Kim YI, Dudek FE. Intracellular electrophysiological study of suprachiasmatic nucleus neurons in rodents: inhibitory synaptic mechanisms. J Physiol 1992;458:247-260.

44. Kornhauser JM, Mayo KE, Takahashi JS. Light, immediate-early genes, and circadian rhythms. Behav Genet 1996;26:221-240.

45. Lehman MN, Silver R, Gladstone WR, Kahn RM, Gibson M, Bittman EL. Circadian rhythmicity restored by neural transplant: Immunocytochemical characterization of the graft and its integration with the host brain. J Neurosci 1987;7:1626-1638.

46. Lemmer B. Clinical chronopharmacology: The importance of time in drug treatment. In: Chadwick DJ, Ackrill K, eds. Circadian clocks and their adjustment. New York: John Wiley, 1995;235-253.

47. Lewy AJ, Sack RL, Blood ML, Bauer VK, Cutler NL, Thomas KH. Melatonin marks circadian phase position and resets the endogenous circadian pacemaker in humans. In: Chadwick DJ, Ackrill K, eds. Circadian clocks and their adjustment. New York: John Wiley, 1995;303-316.

48. Lewy AJ, Sack RL, Miller LS, Hoban TM. Antidepressant and circadian phase-shifting effects of light. Science 1987;235:352-354.

49. Liou SY, Shibata S, Yamakawa K, Ueki S. Inhibitory and excitatory effects of histamine on suprachiasmatic neurons in rat hypothalamic slice preperation. Neurosci Lett 1983;41:109-113.

50. Liu C, Gillette MU. Cholinergic regulation of the SCN circadian rhythm via a muscarinic mechanism at night. J Neurosci 1996;16:744-751.

51. McArthur AJ, Gillette MU, Prosser RA. Melatonin directly resets the rat suprachiasmatic circadian clock in vitro. Brain Res 1991;565:158-161.

52. Medanic M, Gillette MU. Serotonin regulates the phase of the rat suprachiasmatic circadian pacemaker in vitro during the subjective day. J Physiol 1992;450:629-642.

53. Meijer JH, van der Zee EA, Dietz M. Glutamate phase shifts circadian activity rhythms in hamsters. Neurosci Lett 1988;86:177-179.

54. Michel S, Geusz ME, Zaritsky JJ, Block GD. Circadian rhythm in membrane conductance expressed in isolated neurons. Science 1993;259:239-241.

55. Minors DS, Waterhouse JM. Circadian rhythms and the human. London: Wright,1981.

56. Mirmiran M, Swaab DF, Hofman MA, Witting W, Van Gool WA. Circadian rhythms and the suprachiasmatic nucleus in perinatal development, aging and Alzheimer's disease. Prog Brain Res 1992;93:151-163.

57. Mistlberger RE. Circadian food-anticipatory activity: Formal models and physiological mechanisms. Neurosci Biobehav Rev 1994;18:171-195.

58. Moffett JR, Williamson L, Palkovits M, Namboodiri MAA. N-Acetylaspartlyglutamate: A transmitter candidate for the retinohypothalamic tract. Proc Natl Acad Sci USA 1990;87:8065-8069.

59. Moore RY. Organization of the primate circadian system. J Biol Rhythms 1993;8:S3-S9.

60. Moore RY. Neural control of the pineal gland. Behav Brain Res 1996;73:125-130.

61. Moore RY, Eichler VB. Loss of a circadian adrenal corticosterone rhythm following suprachiasmatic lesions in the rat. Brain Res 1972;42:201-206.

62. Moore RY, Halaris AE, Jones BE. Serotonin neurons of the midbrain raphe: ascending projections. J Comp Neurol 1978;180:417-438.

63. Moore RY, Speh JC. GABA is the principal neurotransmitter of the circadian system. Neurosci Lett 1993;150:112-116.

64. Moore RY, Speh JC. A putative retinohypothalamic projection containing substance P in the human. Brain Res 1994;659:249-253.

65. Morin LP, Blanchard J. Depletion of brain serotonin by 5-7-DHT modifies hamster circadian rhythm response to light. Brain Res 1991;566:173-185.

66. Morin LP. The circadian visual system. Brain Res Rev 1994;19:102-127.

67. Mrosovsky N. A non-photic gateway to the circadian clock of hamsters. In: Chadwick DJ, Ackrill K, eds. Circadian clocks and their adjustment. New York: John Wiley, 1995;154-174.

68. Murakami N, Takamure M, Takahashi K, Utunomity A, Kuroda H, Etoh T. Long-term cultured neurons from rat suprachiasmatic nucleus retain the capacity for circadian oscillation of vasopressin release. Brain Res 1991;545:347-350.

69. Piggins HD, Antle MC, Rusak B. Neuropeptides phase shift the mammalian circadian pacemaker. J Neurosci 1995;15:5612-5622.

70. Pincus DJ, Beam WR, Martin RJ. Chronobiology and chronotherapy of asthma. Clin Chest Med 1995;16:699-713.

71. Pittendrigh CS. Circadian systems: General perspective. In: Aschoff J, ed. Handbook of behavioral neurobiology: Biological rhythms. New York: Plenum Press, 1981;57-123.

72. Pittendrigh CS, Daan S. A functional analysis of circadian pacemakers in nocturnal rodents: I. the stability and lability of spontaneous frequency. J Comp Physiol 1976;106:223-252.

73. Prosser RA, McArther AJ, Gillette MU. cGMP induces phase shifts of mammalian circadian pacemaker at night in antiphase to cAMP effect. Proc Natl Acad Sci USA 1989;86:6812-6815.

74. Ralph MR, Menaker M. A mutation of the circadian system in the golden hamster. Science 1988;241:1225-1227.

75. Ralph MR, Menaker M. GABA regulation of circadian responses to light. J Neurosci 1989;9:2858-2865.

76. Ralph MR, Lehman MN. Transplantation: a new tool in the analysis of the mammalian hypothalamic circadian pacemaker. Trends Neurosci 1991;14:362-366.

77. Rea MA, Barrera J, Glass JD, Gannon RL. Serotonergic potentiation of photic phase shifts of the circadian activity rhythm. Neuroreport 1995;6:1289-1292.

78. Rea MA, Glass JD, Colwell CS. Serotonin modulates photic responses in the hamster suprachiasmatic nuclei. J Neurosci 1994;14:3635-3642.

79. Recht LD, Lew RA, Schwartz WJ. Baseball teams beaten by jet lag. Nature 1995;377:583.

80. Reppert SM, Sauman I. period and timeless tango: A dance of two clock genes. Neuron 1995;15:983-986.

81. Reppert SM, Schwartz WJ, Uhl GR. Arginine vasopressin: A novel peptide in cerebrospinal fluid. Trends Neurosci 1987;10:76-80.

82. Rosenthal NE, Sack DA, Gillin JC, Lewy AJ, Goodwin FK, Davenport Y, Mueller PS, Newsome DA, Weher TA. Seasonal affective disorder: a description of the syndrome and preliminary findings with light therapy. Arch Gen Psychiatry 1984;41:72-80.

83. Scheving LE, Burns ER, Pauly JE, Halberg F, Haus E. Survival and cure of leukemic mice after circadian optimization of treatment with cyclophosphamide and 1-b-D-arabinofuranosylcytosine. Cancer Res 1977;37:3648-3655.

84. Schwartz WJ. SCN metabolic activity in vivo. In: Klein DC, Moore RY, Reppert SM, eds. The suprachiasmatic nucleus: The mind's clock. New York: Oxford Univ. Press, 1991;144-156.

85. Schwartz WJ, Bosis NA, Hedley-Whyte ET. A discrete lesion of ventral hypothalamus and optic chiasm that disturbed the daily temperature rhythm. J Neurol 1986;233:1-4.

86. Schwartz WJ, Gross RA, Morton MT. The suprachiasmatic nuclei contain a tetrodotoxin-resistant circadian pacemaker. Proc Natl Acad Sci USA 1987;84:1694-1698.

87. Scott G, Rusak B. Activation of hamster suprachiasmatic neurons in vitro via metabotropic glutamate receptors. Neuroscience 1996;71:533-541.

88. Shibata S, Tsuneyoshi A, Hamada T, Tominaga K, Watanabe S. Effect of substance P on circadian rhythms of firing activity and the 2-deoxyglucose uptake in the rat suprachiasmatic nucleus in vitro. Brain Res 1992;597:257-263.

89. Shibata S, Watanabe A, Hamada T, Ono M, Watanabe S. N-methyl-D-aspartate induces phase shifts of the circadian rhythm of neuronal activity of the rat suprachiasmatic nucleus in vitro. Am J Physiol 1994;267:R360-R364.

90. Silver R, Lehman MN, Gibson M, Gladstone WR, Bittman EL. Dispersed cell suspension of fetal SCN restore circadian rhythmicity in SCN-lesioned adult hamsters. Brain Res 1990;525:45-58.

91. Silver R, LeSauter J. Efferent signals of the suprachiasmatic nucleus. J Biol Rhythms 1993;8:S89-S92.

92. Stephan FK, Zucher I. Circadian rhythms in drinking behavior and locomotor activity of rats are eliminated by hypothalamic lesions. Proc Natl Acad Sci USA 1972;69:1583-1586.

93. Terman M, Task Force Report on light treatment for sleep disorders. J Biol Rhythms 1995;10:99-175.

94. Tosini G, Menaker M. Circadian rhythms in cultured mammalian retina. Science 1996;272:419-421.

95. Turek FW, Pinto LH, Vitaterna MH, Penev PD, Zee PC, Takahashi JS. Pharmacological and genetic approaches for the study of circadian rhythms in mammals. Front Neuroendocrinol 1995;16:191-223.

96. Uhl GR, Reppert SM. Suprachiasmatic nucleus vasopressin messenger RNA: Circadian variations in normal and Brattleboro rats. Science 1986;232:390-393.

97. van den Pol AN. The hypothalamic suprachiasmatic nucleus of the rat: intrinsic anatomy. J Comp Neurol 1980;191:661-702.

98. van den Pol AN, Dudek FE. Cellular communication in the circadian clock, the suprachiasmatic nucleus. Neuroscience 1993;56:793-811.

99. van den Pol AN, Tsyjimoto KL. Neurotransmitters of the hypothalamic suprachiasmatic nucleus: Immunocytochemical analysis of 25 neuronal antigens. Neuroscience 1985;15:1049-1086.

100. Vitaterna MH, King DP, Chang AM, et al. Mutagenesis and mapping of a mouse gene, clock, essential for circadian behavior. Science 1994;264:719-725.

101. Watts AG. The efferent projections of the suprachiasmatic nucleus: anatomical insights into the control of circadian rhythms. In: Klein DC, Moore RY, Reppert SM, eds. The suprachiasmatic nucleus: The mind's clock. New York: Oxford Univ. Press, 1991;77-106.

102. Weaver DR, Rivkees SA, Reppert SM. Localization and characterization of melatonin receptors in rodent brain by in vitro autoradiography. J Neurosci 1989;9:2581-2590.

103. Welsh DK, Logothetis DE, Meister M, Reppert SM. Individual neurons dissociated from rat suprachiasmatic nucleus express independently phased circadian firing rhythms. Neuron 1995;14:697-706.

104. Wollnik F, Brysch W, Uhlmann E, et al. Block of c-Fos and JunB expression by antisense oligonucleotides inhibits light-induced phase shifts of the mammalian circadian clock. Eur J Neurosci 1995;7:388-393.

105. Ying SW, Rusak B. Effects of serotonergic agonists on firing rates of photically responsive cells in the hamster suprachiasmatic nucleus. Brain Res 1994;651:37-46.